New in vitro findings about halogenated boroxine cytotoxicity and deregulation of cell death-related genes in GR-M melanoma cells

Elez-Burnjaković, Nikolina; Pojskić, Lejla; Haverić, Anja; Lojo-Kadrić, Naida; Omanović, Maida Hadžić; Ramić, Jasmin; Smajlović, Ajla; Maksimović, Milka; Haverić, Sanin

doi:10.2478/aiht-2023-74-3702

References

Tsao H, Atkins MB, Sober AJ. Management of cutaneous melanoma. N Engl J Med 2004;351:998–1012. doi: 10.1056/NEJMra041245
Open DOI Search in Google Scholar Back to article
Hintzsche JD, Gorden NT, Amato CM, Kim J, Wuensch KE, Robinson SE, Applegate AJ, Couts KL, Medina TM, Wells KR, Wisell JA, McCarter MD, Box NF, Shellman YG, Gonzalez RC, Lewis KD, Tentler JJ, Tan AC, Robinson WA. Whole-exome sequencing identifies recurrent SF3B1 R625 mutation and comutation of NF1 and KIT in mucosal melanoma. Melanoma Res 2017;27:189–99. doi: 10.1097/CMR.0000000000000345
Open DOI Search in Google Scholar Back to article
Harel M, Ortenberg R, Varanasi SK, Mangalhara KC, Mardamshina M, Markovits E, Baruch EN, Tripple V, Arama-Chayoth M, Greenberg E, Shenoy A, Ayasun R, Knafo N, Xu S, Anafi L, Yanovich-Arad G, Barnabas GD, Ashkenazi S, Besser MJ, Schachter J, Bosenberg M, Shadel GS, Barshack I, Kaech SM, Markel G, Geiger T. Proteomics of melanoma response to immunotherapy reveals mitochondrial dependence. Cell 2019;179:236–50.e18. doi: 10.1016/j.cell.2019.08.012
Open DOI Search in Google Scholar Back to article
Perini GF, Ribeiro GN, Pinto Neto JV, Campos LT, Hamerschlak N. BCL-2 as therapeutic target for hematological malignancies. J Hematol Oncol 2018;11(1):65. doi: 10.1186/s13045-018-0608-2
Open DOI Search in Google Scholar Back to article
Murphy E, Imahashi K, Steenbergen C. Bcl-2 regulation of mitochondrial energetics. Trends Cardiovas Med 2005;15:283–90. doi: 10.1016/j.tcm.2005.09.002
Open DOI Search in Google Scholar Back to article
Nys K, Agostinis P. Bcl-2 family members: essential players in skin cancer. Cancer Lett 2012;320:1–13. doi: 10.1016/j.canlet.2012.01.031
Open DOI Search in Google Scholar Back to article
Kang R, Zeh HJ, Lotze MT, Tang D. The Beclin 1 network regulates autophagy and apoptosis. Cell Death Differ 2011;18:571–80. doi: 10.1038/cdd.2010.191
Open DOI Search in Google Scholar Back to article
Mgrditchian T, Arakelian T, Paggetti J, Noman MZ, Viry E, Moussay E, Van Moer K, Kreis S, Guerin C, Buart S, Robert C, Borg C, Vielh P, Chouaib S, Berchem G, Janji B. Targeting autophagy inhibits melanoma growth by enhancing NK cells infiltration in a CCL5-dependent manner. Proc Natl Acad Sci U S A 2017;114(44):E9271–9. doi: 10.1073/pnas.1703921114
Open DOI Search in Google Scholar Back to article
Pojskić L, Haverić S, Lojo-Kadrić N, Hadzić M, Haverić A, Galić Z, Galić B, Vullo D, Supuran CT, Milos M. Effects of dipotassium-trio xohydroxytetrafluorotriborate, K₂[B₃O₃F₄OH], on cell viability and gene expression of common human cancer drug targets in a melanoma cell line. J Enzyme Inhib Med Chem 2016;31:999–1004. doi: 10.3109/14756366.2015.1078329
Open DOI Search in Google Scholar Back to article
Galić B. Boroxine composition for removal of skin changes. Patent US 8, 278, 289 B22 October 2, 2012 [displayed 28 February 2023]. Available at https://patentimages.storage.googleapis.com/9b/b7/82/939ed401b099e9/US8278289.pdf
Search in Google Scholar Back to article
Ivanković S, Stojković R, Galić Z, Galić B, Ostojić J, Marasović M, Miloš M. In vitro and in vivo antitumor activity of the halogenated boroxine dipotassium trioxohydroxytetrafluorotriborate (K₂[B₃O₃F₄OH]). J Enzyme Inhib Med Chem 2015;30:354–9. doi: 10.3109/14756366.2014.926344
Open DOI Search in Google Scholar Back to article
Hadžić M, Pojskić L, Lojo-Kadrić N, Haverić A, Ramić J, Galić B, Haverić S. Novel boron-containing compound, halogenated boroxine, induces selective cytotoxicity through apoptosis triggering in UT-7 leukemia. J Biochem Mol Toxicol 2022;36(5):e23005. doi: 10.1002/jbt.23005
Open DOI Search in Google Scholar Back to article
Haverić S, Haverić A, Bajrović K, Galić B, Maksimović M. Effects of dipotassium trioxohydroxytetrafluorotriborate (K₂[B₃O₃F₄OH]) on genetic material and inhibition of cell division in human cell cultures. Drug Chem Toxicol 2011;34:250–4. doi: 10.3109/01480545.2010.507207
Open DOI Search in Google Scholar Back to article
Islamović S, Galić B, Miloš M. A study of the inhibition of catalase by dipotassium trioxohydroxytetrafluorotriborate K₂[B₃O₃F₄OH]. J Enzyme Inhib Med Chem 2014;29:744–8. doi: 10.3109/14756366.2013.848203
Open DOI Search in Google Scholar Back to article
Ostojić J, Herenda S, Galijašević S, Galić B, Miloš M. Inhibition of horseradish peroxidase activity by boroxine derivative, dipotassium-tr ioxohydroxytetrafluorotriborate K₂[B₃O₃F₄OH]. J Chem 2017;2017:8134350. doi: 10.1155/2017/8134350
Open DOI Search in Google Scholar Back to article
Herenda S, Ostojić J, Hasković E, Hasković D, Miloš M, Galić B. Electrochemical investigation of the influence of K₂[B₃O₃F₄OH] on the activity of immobilized superoxide dismutase. Int J Electrochem Sci 2018;13:3279–87. doi: 10.20964/2018.04.35
Open DOI Search in Google Scholar Back to article
Vullo D, Miloš M, Galić B, Scozzafava A, Supuran CT. Dipotassium trioxohydroxytetrafluorotriborate K₂[B₃O₃F₄OH], is a potent inhibitor of human carbonic anhydrases. J Enzyme Inhib Med Chem 2015;30:341–4. doi: 10.3109/14756366.2014.918610
Open DOI Search in Google Scholar Back to article
Ivanković S, Stojković R, Maksimović M, Galić B, Miloš M. Impact of calcium ion on cytotoxic effect of the boroxine derivative, K₂[B₃O₃F₄OH]. J Enzyme Inhib Med Chem 2016;31(Suppl 3):70–4. doi: 10.1080/14756366.2016.1204611
Open DOI Search in Google Scholar Back to article
Hadzic M, Sun Y, Tomic N, Tsirvouli E, Kuiper M, Pojskic L. Halogenated boroxine increases propensity to apoptosis in leukemia (UT-7) but not non-tumor cells in vitro. FEBS Open Bio 2023;13:143–53. doi: 10.1002/2211-5463.13522
Open DOI Search in Google Scholar Back to article
Easty DJ, Guthrie BA, Maung K, Farr CJ, Lindberg RA, Toso RJ, Herlyn M, Bennett DC. Protein B61 as a new growth factor: expression of B61 and up-regulation of its receptor epithelial cell kinase during melanoma progression. Cancer Res 1995;55:2528–32. PMID: 7780963
Search in Google Scholar Back to article
Panda SK, Ravindran B. Isolation of human PBMCs. Bio-protocol 2013;3(3):e323. doi: 10.21769/BioProtoc.323
Open DOI Search in Google Scholar Back to article
Rampersad SN. Multiple applications of Alamar Blue as an indicator of metabolic function and cellular health in cell viability bioassays. Sensors 2012;12:12347–60. doi: 10.3390/s120912347
Open DOI Search in Google Scholar Back to article
Kumar P, Nagarajan A, Uchil PD. Analysis of cell viability by the alamarBlue assay. Cold Spring Harb Protoc 2018;6:095489. doi: 10.1101/pdb.prot095489
Open DOI Search in Google Scholar Back to article
AlamarBlue^® Assay, U.S. Patent No. 5,501,959 [displayed 22 February 2023]. Available at https://tools.thermofisher.com/content/sfs/manuals/PI-DAL1025-1100_TI%20alamarBlue%20Rev%201.1.pdf
Search in Google Scholar Back to article
Wagner EM. Monitoring gene expression: quantitative real-time rt-PCR. Methods Mol Biol 2013;1027:19–45. doi: 10.1007/978-1-60327-369-5_2
Open DOI Search in Google Scholar Back to article
Pfaffl MW, Horgan GW, Dempfle L. Relative expression software tool (REST) for group wise comparison and statistical analysis of relative expression results in real-time PCR. Nucleic Acids Res 2002;30(9):e36. doi: 10.1093/nar/30.9.e36
Open DOI Search in Google Scholar Back to article
Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2^-ΔΔCT method. Methods 2001;25:402–8. doi: 10.1006/meth.2001.1262
Open DOI Search in Google Scholar Back to article
Zhang XD, Qi L, Wu JC, Qin ZH. DRAM1 regulates autophagy flux through lysosomes. PLoS One 2013;8(5):e63245. doi: 10.1371/journal.pone.0063245
Open DOI Search in Google Scholar Back to article
Galavotti S, Bartesaghi S, Faccenda D, Shaked-Rabi M, Sanzone S, McEvoy A, Dinsdale D, Condorelli F, Brandner S, Campanella M, Grose R, Jones C, Salomoni P. The autophagy-associated factors DRAM1 and p62 regulate cell migration and invasion in glioblastoma stem cells. Oncogene 2013;32:699–712. doi: 10.1038/onc.2012.111
Open DOI Search in Google Scholar Back to article
Vats S, Manjithaya R. A reversible autophagy inhibitor blocks autophagosome-lysosome fusion by preventing Stx17 loading onto autophagosomes. Mol Biol Cell 2019;30:2283–95. doi: 10.1091/mbc.E18-08-0482
Open DOI Search in Google Scholar Back to article
Kumar AV, Mills J, Lapierre LR. Selective autophagy receptor p62/SQSTM1, a pivotal player in stress and aging. Front Cell Dev Biol 2022;10:793328. doi: 10.3389/fcell.2022.793328
Open DOI Search in Google Scholar Back to article

New in vitro findings about halogenated boroxine cytotoxicity and deregulation of cell death-related genes in GR-M melanoma cells

References

Paradigm

My account